Evidence map›Paper›PMID 24529379›Full record

ArticleCell2014

Spatial control of the TSC complex integrates insulin and nutrient regulation of mTORC1 at the lysosome.

Suchithra Menon, Christian C Dibble, George Talbott, Gerta Hoxhaj, Alexander J Valvezan, Hidenori Takahashi, Lewis C Cantley, Brendan D Manning

Open access · bronzeAbstract read
In one paragraph

Article in Cell, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 515 papers.

0numbers the graph read from it
0cells of the map it votes in
515citing papers in PubMed
33.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

515 citing papers in PubMed, 762 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Drug resistant epilepsy driven byEpilepsy & behavior reports · 2026
    Article
  13. Article
  14. Article
  15. Review
  16. Tuberous sclerosis complex.Nature reviews. Disease primers · 2026
    Review
  17. Article
  18. Article
  19. Article
  20. Article

455 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Suchithra MenonDepartment of Genetics and Complex Diseases, Harvard School of Public Health, Boston, MA 02115, USA.
Christian C DibbleDepartment of Systems Biology, Harvard Medical School and Division of Signal Transduction, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA. Electronic address: ccdibble@bidmc.harvard.edu.
George TalbottDepartment of Genetics and Complex Diseases, Harvard School of Public Health, Boston, MA 02115, USA.
Gerta HoxhajDepartment of Genetics and Complex Diseases, Harvard School of Public Health, Boston, MA 02115, USA.
Alexander J ValvezanDepartment of Genetics and Complex Diseases, Harvard School of Public Health, Boston, MA 02115, USA.
Hidenori TakahashiDepartment of Systems Biology, Harvard Medical School and Division of Signal Transduction, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.
Lewis C CantleyDepartment of Systems Biology, Harvard Medical School and Division of Signal Transduction, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA; Department of Medicine, Weill Cornell Medical College, New York, NY 10065, USA.
Brendan D ManningDepartment of Genetics and Complex Diseases, Harvard School of Public Health, Boston, MA 02115, USA. Electronic address: bmanning@hsph.harvard.edu.
Harvard University · USCornell University · US

Funding

Tuberous Sclerosis-Pathway and PathogenesisP01CA120964 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI David J. Kwiatkowski · 2007 to 2026
$35.9M
Training Program in Angiogenesis &InflammationT32HL007893 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI DVORAK, HAROLD FISHER · 1998 to 2017
$5.5M
The Role of PI3K in Growth RegulationR01GM041890 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI CANTLEY, LEWIS C. · 1990 to 2016
$4.1M
Regulatory mechanisms and role of the PI3K-TSC-mTOR signaling network in tumorsR01CA122617 · NCI · HARVARD SCHOOL OF PUBLIC HEALTH · PI MANNING, BRENDAN D. · 2006 to 2015
$2.7M
NCI NIH HHS P01 CA120964NCI NIH HHS P01-CA120964NCI NIH HHS R01 CA122617NCI NIH HHS R01-CA122617NHLBI NIH HHS T32 HL007893NHLBI NIH HHS T32-HL007893NIGMS NIH HHS R01 GM041890
6 · The paper itself

Abstract

mTORC1 promotes cell growth in response to nutrients and growth factors. Insulin activates mTORC1 through the PI3K-Akt pathway, which inhibits the TSC1-TSC2-TBC1D7 complex (the TSC complex) to turn on Rheb, an essential activator of mTORC1. However, the mechanistic basis of how this pathway integrates with nutrient-sensing pathways is unknown. We demonstrate that insulin stimulates acute dissociation of the TSC complex from the lysosomal surface, where subpopulations of Rheb and mTORC1 reside. The TSC complex associates with the lysosome in a Rheb-dependent manner, and its dissociation in response to insulin requires Akt-mediated TSC2 phosphorylation. Loss of the PTEN tumor suppressor results in constitutive activation of mTORC1 through the Akt-dependent dissociation of the TSC complex from the lysosome. These findings provide a unifying mechanism by which independent pathways affecting the spatial recruitment of mTORC1 and the TSC complex to Rheb at the lysosomal surface serve to integrate diverse growth signals.

Indexed as

Amino AcidsAnimalsCell LineGTP PhosphohydrolasesHumansInsulinLysosomesMechanistic Target of Rapamycin Complex 1MiceMultiprotein ComplexesPhosphatidylinositol 3-KinasesPhosphorylationTOR Serine-Threonine KinasesTuberous Sclerosis Complex 2 ProteinTumor Suppressor ProteinsAmino AcidsGTP PhosphohydrolasesInsulinMechanistic Target of Rapamycin Complex 1Multiprotein ComplexesPhosphatidylinositol 3-KinasesTOR Serine-Threonine KinasesTSC2 protein, humanTsc2 protein, mouseTuberous Sclerosis Complex 2 ProteinTumor Suppressor Proteins

Identifiers

PMID24529379
PMCPMC4030681
OpenAlexW2060607801

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.